The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases

Oded Shamriz; Alon Y. Hershko; Aviv Talmon; Yaarit Ribak; Anat Scheiman Elazary; Liran Horev; Adeeb NaserEddin; Tzahi Neuman; Sheer Shabat; Abraham Zlotogorski; Yuval Tal

doi:10.1016/j.alit.2020.10.001

The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases

Oded Shamriz, Alon Y. Hershko^*, Aviv Talmon, Yaarit Ribak, Anat Scheiman Elazary, Liran Horev, Adeeb NaserEddin, Tzahi Neuman, Sheer Shabat, Abraham Zlotogorski, Yuval Tal

^*Corresponding author for this work

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	266-268
Number of pages	3
Journal	Allergology International
Volume	70
Issue number	2
DOIs	https://doi.org/10.1016/j.alit.2020.10.001
State	Published - Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.alit.2020.10.001

Cite this

@article{0ead728d3683412cab628fddc877e05a,

title = "The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases",

author = "Oded Shamriz and Hershko, {Alon Y.} and Aviv Talmon and Yaarit Ribak and Elazary, {Anat Scheiman} and Liran Horev and Adeeb NaserEddin and Tzahi Neuman and Sheer Shabat and Abraham Zlotogorski and Yuval Tal",

year = "2021",

month = apr,

doi = "10.1016/j.alit.2020.10.001",

language = "אנגלית",

volume = "70",

pages = "266--268",

journal = "Allergology International",

issn = "1323-8930",

publisher = "Japanese Society of Allergology",

number = "2",

}

TY - JOUR

T1 - The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases

AU - Shamriz, Oded

AU - Hershko, Alon Y.

AU - Talmon, Aviv

AU - Ribak, Yaarit

AU - Elazary, Anat Scheiman

AU - Horev, Liran

AU - NaserEddin, Adeeb

AU - Neuman, Tzahi

AU - Shabat, Sheer

AU - Zlotogorski, Abraham

AU - Tal, Yuval

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85096160008&partnerID=8YFLogxK

U2 - 10.1016/j.alit.2020.10.001

DO - 10.1016/j.alit.2020.10.001

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 33779559

AN - SCOPUS:85096160008

SN - 1323-8930

VL - 70

SP - 266

EP - 268

JO - Allergology International

JF - Allergology International

IS - 2

ER -

The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases

UN SDGs

Access to Document

Other files and links

Cite this